Abstract :
Global surveys reveal continued worsening of type 2 diabetes in developing countries. In the Middle East, there is an escalation in the prevalence of diabetes, with parallel increases in obesity and the metabolic syndrome. The Middle East is expected to have the highest increases in type 2 diabetes prevalence by the year 2030, as compared to other regions of the world. Parallel to that, there will be significant worsening of cardiovascular mortality and morbidity, with concomitant health, economic and psychosocial implications.
